4.8 Article

Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk

Journal

NATURE GENETICS
Volume 44, Issue 1, Pages 58-U83

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.993

Keywords

-

Funding

  1. Heinz-Nixdorf Foundation
  2. German Centre for Neurodegenerative Disorders (DZNE), Bonn
  3. Myeloma UK
  4. Cancer Research UK [C1298/A8362]
  5. Bobby Moore Fund
  6. Leukaemia Lymphoma Research Fund
  7. National Health Services (NHS) through the Biological Research Centre of the National Institute for Health Research at the Royal Marsden Hospital NHS Trust
  8. APO-STS (European Union) [Health-F4-2007-200767]
  9. German Ministry of Education and Science
  10. German Research Council (DFG) [SI 236/8-1, SI236/9-1, ER 155/6-1]

Ask authors/readers for more resources

To identify risk variants for multiple myeloma, we conducted a genome-wide association study of 1,675 individuals with multiple myeloma and 5,903 control subjects. We identified risk loci for multiple myeloma at 3p22.1 (rs1052501 in ULK4; odds ratio (OR) = 1.32; P = 7.47 x 10(-9)) and 7p15.3 (rs4487645, OR = 1.38; P = 3.33 x 10(-15)). In addition, we observed a promising association at 2p23.3 (rs6746082, OR = 1.29; P = 1.22 x 10(-7)). Our study identifies new genomic regions associated with multiple myeloma risk that may lead to new etiological insights.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available